Interius Biotherapeutics
Thomas O'Malley works as a Principal Scientist, specializing in Analytical Development at Interius Biotherapeutics. Prior to this role, Thomas held positions in various companies such as Tmunity Therapeutics Incorporated, WuXi Advanced Therapies, The Children's Hospital of Philadelphia, and University of Pennsylvania. With a background in developing assays for lentiviral vector preparations and CAR T-cell products, Thomas has extensive experience in gene therapy and lysosomal storage diseases. Additionally, Thomas has a Bachelor of Science from Villanova University.
Interius Biotherapeutics
1 followers
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.